Skip to content

Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?

Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently? - DIONYSIUS

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52592
Enrollment
150
Registered
2020-08-13
Start date
2021-10-08
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic diabetic foot ulcer wound on the foot with vascular insufficiency

Interventions

Patients receive 20, 30 or 40 sessions of HBOT. The sessions last between the 90 and 120 minutes at 2.2-2.5 ATA.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Type I or II diabetes 2. Meggitt-Wagner 3 or 4 lower extremity ulcer(s), present for at least 4 weeks or after a minor amputation because of a previously existing ischemic DFU. In case more than one ulcer is present, the largest will be observed as target ulcer 3. Leg ischemia, characterized by a highest ankle systolic blood pressure

Exclusion criteria

Exclusion criteria: 1. Chronic Obstructive Pulmonary Disease (COPD) GOLD IV 2. Treatment with chemotherapy, immunosuppressive drugs or systemic corticosteroids within last 3 months, as this interferes with normal wound healing 3. End-stage renal disease requiring dialysis 4. Metastasized malignancy 5. Left ventricular failure with ejection fraction (EF)

Design outcomes

Primary

MeasureTime frame
Major amputation rate (above ankle) and (major)l after 3 years of follow-up

Secondary

MeasureTime frame
- Amputation-free survival - Health-related quality of life - Complete wound healing - Pain scores - Need for additional (vascular) interventions - Cost-effectiveness and budget impact - Mortality - Patients perception of improvement - TcpO2 before, during and after HBOT

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)